CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...